Answers are grounded in this paper and cite their sources.
BACKGROUND: Prostate cancer (PC) is the second most common solid cancer affecting men. LncRNA PCAT19 has a carcinogenic role in multiple solid and hematological cancers. Additionally, miR-195 was significantly downregulated in multiple malignancies. Moreover, ITGA6 promotes pathways that control carcinogenesis. E-cadherin is a glycoprotein involved in epithelial cell adhesion and maintaining tissue integrity. E-cadherin loss is related to epithelial-mesenchymal transition (EMT) and cancer metastasis. This preliminary study investigated the expression of PCAT19, miR-195, ITGA6, and E-cadherin in PC tissues. SUBJECTS & METHODS: Seventy-two tissue specimens from 36 PC patients were enrolled in this study. The diseased group included 36 primary PC tissues, and the control group included 36 specimens from their non-neoplastic adjacent tissues. Gene expression of LncRNA PCAT19, miR-195, and ITGA6 in tissues was estimated by Reverse transcription- quantitative polymerase chain reaction (RT-qPCR), and E-cadherin expression was detected by immunohistochemistry. RESULTS: A statistically significant upregulation inPCAT19 (7.92-fold) and ITGA6 (6.67-fold) gene expression and downregulation of miR-195 (4.17-fold) gene expression in tumor tissues compared to adjacent non-neoplastic tissues were recorded. During follow-up, 11 of 36 patients (30.6%) died, and disease progression occurred in 6 of 25 evaluable patients (24.0%). There was a statistically significant decrease in PCAT19 and ITGA6 and an increase in miR-195 among surviving cases compared with dead cases. Receiver operating characteristic (ROC) curve analysis revealed that PCAT19 at a cutoff of > 8.89-fold demonstrated promising discriminatory performance for advanced-stage PC, with an area under the curve (AUC) of 0.84 (95% confidence interval (CI): 0.69-0.99, P < 0.001), 70% sensitivity, 93.7% specificity, 93.3% positive predictive value, 71.4% negative predictive value, and an overall diagnostic accuracy of 80.6%. In comparison, ITGA6 (AUC = 0.73) and miR-195 (AUC = 0.71) exhibited only fair discriminatory ability. CONCLUSION: Upregulation of PCAT19 and ITGA6, and downregulation of miR-195, in prostate cancer tissues may be associated with disease aggressiveness.
No takes yet. Share an insight, caveat, or question.
Hussein et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: